Karuna Therapeutics, Inc.
KRTX · NASDAQ
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $11,958,064 | $6,372,857 | $8,137,218 | $6,321,189 |
| - Cash | $185,823 | $184,471 | $263,603 | $562,660 |
| + Debt | $16,688 | $15,609 | $15,810 | $4,759 |
| Enterprise Value | $11,788,929 | $6,203,995 | $7,889,425 | $5,763,288 |
| Revenue | $0 | $0 | $0 | $654 |
| % Growth | – | – | -100% | – |
| Gross Profit | -$447 | -$458 | -$469 | $327 |
| % Margin | – | – | – | 50% |
| EBITDA | -$101,215 | -$135,760 | -$119,438 | -$108,739 |
| % Margin | – | – | – | -16,626.8% |
| Net Income | -$113,824 | -$119,119 | -$103,163 | -$86,082 |
| % Margin | – | – | – | -13,162.4% |
| EPS Diluted | -3.01 | -3.16 | -2.75 | -2.47 |
| % Growth | 4.7% | -14.9% | -11.3% | – |
| Operating Cash Flow | -$111,059 | -$109,997 | -$64,134 | -$100,629 |
| Capital Expenditures | -$799 | -$629 | -$775 | -$714 |
| Free Cash Flow | -$111,858 | -$110,626 | -$64,909 | -$101,343 |